Bora CDMO Bora CDMO

X

Find the latest news about Ractigen Therapeutics aggregated by PharmaCompass.com.

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Ractigen Therapeutics
China Flag
Country
Country
China
Address
Address
Bldg.18, Rudong Life & Health Industry Park, 888 Zhujiang Rd, Rudong, Nantong, Jiangsu Province
Telephone
Telephone
(+86) 513-81996959

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.prnewswire.com/news-releases/ractigen-therapeutics-enters-strategic-partnership-with-university-medical-center-utrecht-to-drive-sarna-innovation-in-neurodevelopmental-disorders-302046570.html

PR NEWSWIRE
29 Jan 2024

https://www.globenewswire.com/news-release/2023/12/06/2791641/0/en/Ractigen-Therapeutics-Advances-into-Clinical-Stage-with-Groundbreaking-saRNA-Drug-RAG-01.html

GLOBENEWSWIRE
06 Dec 2023

https://www.globenewswire.com//news-release/2023/11/02/2772254/0/en/Ractigen-Presents-Preclinical-Results-of-Its-saRNA-Therapeutic-Targeting-DMD-BMD-at-the-Oligonucleotide-Therapeutics-Society-OTS-Annual-Meeting.html

GLOBENEWSWIRE
02 Nov 2023

https://www.globenewswire.com/news-release/2023/06/05/2681805/0/en/Ractigen-Therapeutics-Announces-Dosing-of-First-Patient-in-First-in-Human-Trial-of-RAG-17-for-the-Treatment-of-SOD1-ALS.html

GLOBENEWSWIRE
05 Jun 2023

https://www.globenewswire.com/news-release/2023/03/03/2620288/0/en/Ractigen-Therapeutics-Receives-FDA-Orphan-Drug-Designation-for-the-novel-oligonucleotide-conjugate-RAG-17-for-the-Treatment-of-Amyotrophic-Lateral-Sclerosis-ALS.html

GLOBENEWSWIRE
03 Mar 2023

https://www.globenewswire.com/news-release/2023/01/09/2585044/0/en/Ractigen-Therapeutics-Announces-the-Appointment-of-Harri-J%C3%A4rvel%C3%A4inen-as-Chief-Operating-Officer.html

GLOBENEWSWIRE
09 Jan 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY